For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...
After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...
With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...
Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That ...
Have you ever asked how doctors help the body repair itself when a serious disease damages cells or tissues? Modern medicine ...
In PV and ET, MDS risk remains lower than AML risk but increases progressively with advancing attained age. Transformation to acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood ...
Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children ...
March 19, 2026. More for You ...
Exposure to petrol compounds appears to be associated with an increased risk of childhood leukemia, including acute lymphoblastic leukemia (ALL), according to a systematic review ...
New research suggests that Sjögren’s disease may increase cancer risk in patients and their close relatives. Read more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results